Granzyme B degrades extracellular matrix and promotes inflammation and choroidal neovascularization. 2024

Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
Department of Ophthalmology and Visual Sciences, UBC, Vancouver, BC, Canada.

Age-related macular degeneration (AMD) is a common retinal neurodegenerative disease among the elderly. Neovascular AMD (nAMD), a leading cause of AMD-related blindness, involves choroidal neovascularization (CNV), which can be suppressed by anti-angiogenic treatments. However, current CNV treatments do not work in all nAMD patients. Here we investigate a novel target for AMD. Granzyme B (GzmB) is a serine protease that promotes aging, chronic inflammation and vascular permeability through the degradation of the extracellular matrix (ECM) and tight junctions. Extracellular GzmB is increased in retina pigment epithelium (RPE) and mast cells in the choroid of the healthy aging outer retina. It is further increased in donor eyes exhibiting features of nAMD and CNV. Here, we show in RPE-choroidal explant cultures that exogenous GzmB degrades the RPE-choroid ECM, promotes retinal/choroidal inflammation and angiogenesis while diminishing anti-angiogenic factor, thrombospondin-1 (TSP-1). The pharmacological inhibition of either GzmB or mast-cell degranulation significantly reduces choroidal angiogenesis. In line with our in vitro data, GzmB-deficiency reduces the extent of laser-induced CNV lesions and the age-related deterioration of electroretinogram (ERG) responses in mice. These findings suggest that targeting GzmB, a serine protease with no known endogenous inhibitors, may be a potential novel therapeutic approach to suppress CNV in nAMD.

UI MeSH Term Description Entries

Related Publications

Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
October 2013, Cell death and differentiation,
Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
December 1993, Journal of immunology (Baltimore, Md. : 1950),
Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
January 2020, Frontiers in immunology,
Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
January 2020, Frontiers in immunology,
Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
May 2021, EMBO molecular medicine,
Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
July 2020, Cell reports,
Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
September 2018, Experimental eye research,
Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
October 2002, The American journal of pathology,
Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
November 2019, Advances in wound care,
Gideon Obasanmi, and Manjosh Uppal, and Jing Z Cui, and Jeanne Xi, and Myeong Jin Ju, and Jun Song, and Eleanor To, and Siqi Li, and Wania Khan, and Darian Cheng, and John Zhu, and Lyden Irani, and Isa Samad, and Julie Zhu, and Hyung-Suk Yoo, and Alexandre Aubert, and Jonathan Stoddard, and Martha Neuringer, and David J Granville, and Joanne A Matsubara
January 2020, Frontiers in immunology,
Copied contents to your clipboard!